# The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

> **NCT01368627** · PHASE4 · COMPLETED · sponsor: **Sahajanand Medical Technologies Limited** · enrollment: 1274 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Supralimus® Sirolimus-Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT01368627
- **Lead sponsor:** Sahajanand Medical Technologies Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 1274 (ACTUAL)
- **Last updated:** 2012-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01368627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01368627, "The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01368627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*